Literature DB >> 9155053

Loss of heterozygosity at chromosome 6q in preinvasive and early invasive breast carcinomas.

S A Chappell1, T Walsh, R A Walker, J A Shaw.   

Abstract

We have used polymerase chain reaction (PCR) analysis to study the incidence of allelic imbalance at four polymorphic microsatellite markers on chromosome 6q25.1-27, three dinucleotide repeats and one trinucleotide repeat, for microdissected tumour foci from a group of 75 'early' breast carcinomas. The tumours comprised 16 preinvasive cases of ductal carcinoma in situ (DCIS) and 59 mammographically detected early invasive carcinomas. Loss of heterozygosity (LOH) was detected at all four loci and in all types and grade of disease. The frequency of LOH ranged from 23% to 50% depending on the marker studied. The highest frequency of LOH was observed at the D6S186 locus for the cases of DCIS and at the oestrogen receptor locus for the invasive carcinomas. These data suggest that the inactivation of tumour-suppressor genes within this region on chromosome 6q is important for the development of these early lesions.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9155053      PMCID: PMC2228245          DOI: 10.1038/bjc.1997.224

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  31 in total

1.  Cellular activation of latent transforming growth factor beta requires binding to the cation-independent mannose 6-phosphate/insulin-like growth factor type II receptor.

Authors:  P A Dennis; D B Rifkin
Journal:  Proc Natl Acad Sci U S A       Date:  1991-01-15       Impact factor: 11.205

2.  Trinucleotide repeat polymorphism at the human transcription factor IID gene.

Authors:  M H Polymeropoulos; D S Rath; H Xiao; C R Merril
Journal:  Nucleic Acids Res       Date:  1991-08-11       Impact factor: 16.971

Review 3.  Characterization of chromosomal anomalies in human breast cancer. A comparison of 30 paradiploid cases with few chromosome changes.

Authors:  B Dutrillaux; M Gerbault-Seureau; B Zafrani
Journal:  Cancer Genet Cytogenet       Date:  1990-10-15

4.  Multiple chromosomes carrying tumor suppressor activity for a uterine endometrial carcinoma cell line identified by microcell-mediated chromosome transfer.

Authors:  H Yamada; N Wake; S Fujimoto; J C Barrett; M Oshimura
Journal:  Oncogene       Date:  1990-08       Impact factor: 9.867

5.  Common regions of deletion on chromosomes 5q, 6q, and 10q in renal cell carcinoma.

Authors:  R Morita; S Saito; J Ishikawa; O Ogawa; O Yoshida; K Yamakawa; Y Nakamura
Journal:  Cancer Res       Date:  1991-11-01       Impact factor: 12.701

6.  Loss of heterozygosity for loci on the long arm of chromosome 6 in human malignant melanoma.

Authors:  D Millikin; E Meese; B Vogelstein; C Witkowski; J Trent
Journal:  Cancer Res       Date:  1991-10-15       Impact factor: 12.701

7.  Allelotype of human breast carcinoma: a second major site for loss of heterozygosity is on chromosome 6q.

Authors:  P Devilee; M van Vliet; P van Sloun; N Kuipers Dijkshoorn; J Hermans; P L Pearson; C J Cornelisse
Journal:  Oncogene       Date:  1991-09       Impact factor: 9.867

Review 8.  Chromosomal abnormalities in human breast cancer.

Authors:  W M Mars; G F Saunders
Journal:  Cancer Metastasis Rev       Date:  1990-07       Impact factor: 9.264

9.  Molecular lesions involved in the progression of a human breast cancer.

Authors:  E Liu; C Dollbaum; G Scott; C Rochlitz; C Benz; H S Smith
Journal:  Oncogene       Date:  1988-09       Impact factor: 9.867

Review 10.  Prognostic factors for recurrence and survival in axillary node-negative breast cancer.

Authors:  W L McGuire; G M Clark
Journal:  J Steroid Biochem       Date:  1989       Impact factor: 4.292

View more
  14 in total

1.  Polymorphism in the manganese superoxide dismutase (MnSOD) gene and risk of breast cancer in young women.

Authors:  Malin Bergman; Marie Ahnström; Pia Palmebäck Wegman; Sten Wingren
Journal:  J Cancer Res Clin Oncol       Date:  2005-05-10       Impact factor: 4.553

Review 2.  Matricellular CCN6 (WISP3) protein: a tumor suppressor for mammary metaplastic carcinomas.

Authors:  Mai N Tran; Celina G Kleer
Journal:  J Cell Commun Signal       Date:  2018-01-22       Impact factor: 5.782

3.  Down-regulation of miRNA-30a in human plasma is a novel marker for breast cancer.

Authors:  Rui-chao Zeng; Wei Zhang; Xing-qiang Yan; Zhi-qiang Ye; En-dong Chen; Du-ping Huang; Xiao-hua Zhang; Guan-li Huang
Journal:  Med Oncol       Date:  2013-02-07       Impact factor: 3.064

Review 4.  Growth hormone and insulin-like growth factor-I in the transition from normal mammary development to preneoplastic mammary lesions.

Authors:  David L Kleinberg; Teresa L Wood; Priscilla A Furth; Adrian V Lee
Journal:  Endocr Rev       Date:  2008-12-15       Impact factor: 19.871

Review 5.  Biological features of premalignant disease in the human breast.

Authors:  D C Allred; S K Mohsin
Journal:  J Mammary Gland Biol Neoplasia       Date:  2000-10       Impact factor: 2.673

6.  Loss of imprinting of IGF2 and H19, loss of heterozygosity of IGF2R and CTCF, and Helicobacter pylori infection in laryngeal squamous cell carcinoma.

Authors:  Ivana Grbesa; Marino Marinkovic; Mirko Ivkic; Bozo Kruslin; Renata Novak-Kujundzic; Boris Pegan; Ozren Bogdanovic; Vladimir Bedekovic; Koraljka Gall-Troselj
Journal:  J Mol Med (Berl)       Date:  2008-07-05       Impact factor: 4.599

7.  The emerging role of CCN6 in breast cancer invasion.

Authors:  Guadalupe Lorenzatti; Wei Huang; Celina G Kleer
Journal:  Cellscience       Date:  2009-10

8.  Chromosome 3p allele loss in early invasive breast cancer: detailed mapping and association with clinicopathological features.

Authors:  A Martinez; R A Walker; J A Shaw; S J Dearing; E R Maher; F Latif
Journal:  Mol Pathol       Date:  2001-10

9.  On how CCN6 suppresses breast cancer growth and invasion.

Authors:  Wei Huang; Anupama Pal; Celina G Kleer
Journal:  J Cell Commun Signal       Date:  2011-08-13       Impact factor: 5.782

10.  Inhibition of CCN6 (WISP3) expression promotes neoplastic progression and enhances the effects of insulin-like growth factor-1 on breast epithelial cells.

Authors:  Yanhong Zhang; Quintin Pan; Hui Zhong; Sofia D Merajver; Celina G Kleer
Journal:  Breast Cancer Res       Date:  2005-11-08       Impact factor: 6.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.